# TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis

> **NCT06597188** · NA · ENROLLING_BY_INVITATION · sponsor: **Shanghai MicroPort CardioFlow Medtech Co., Ltd.** · enrollment: 452 (estimated)

## Conditions studied

- Aortic Stenosis
- Bicuspid Aortic Valve (BAV)

## Interventions

- **DEVICE:** VitaFlow Liberty
- **DEVICE:** Commercially available surgical bioprosthetic valve

## Key facts

- **NCT ID:** NCT06597188
- **Lead sponsor:** Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-09-08
- **Primary completion:** 2028-09-30
- **Final completion:** 2032-09-30
- **Target enrollment:** 452 (ESTIMATED)
- **Last updated:** 2025-09-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06597188

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06597188, "TAVR vs. SAVR Study of VitaFlow Liberty® for Severe BAV Stenosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06597188. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*